Genetic alterations such as the amplification of chromosome 9p24.1, which harbors the genes encoding PD-L1 and PD-L2, have been associated with impaired immune surveillance and poorer clinical outcomes in CHL patients [111,112]. Here, CD274 is linked to classic Hodgkin lymphoma.